Cargando…
Systemic effects of the hormonal treatment of male hypogonadism with preliminary indications for the management of COVID-19 patients
Male hypogonadism, defined as an inadequate production of testosterone (T), is associated with a greater morbidity and mortality. Epidemiological studies identified T deficiency as a risk factor for cardiovascular disease. Also, low serum T levels impact on glucose homeostasis through a worse glucos...
Autores principales: | Cannarella, Rossella, Calogero, Aldo E., Condorelli, Rosita A., Aversa, Antonio, La Vignera, Sandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576928/ https://www.ncbi.nlm.nih.gov/pubmed/33133492 http://dx.doi.org/10.1177/2042018820966438 |
Ejemplares similares
-
Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results
por: La Vignera, Sandro, et al.
Publicado: (2023) -
Substance Abuse and Male Hypogonadism
por: Duca, Ylenia, et al.
Publicado: (2019) -
OR25-02 Hunting The Magic Bullet In Treating Male Secondary Hypogonadism Associated With Metabolic Syndrome: Results Of a Prospective Study Comparing Liraglutide Vs. Gonadotropins
por: La Vignera, Sandro, et al.
Publicado: (2023) -
Osteoporosis from an Endocrine Perspective: The Role of Hormonal Changes in the Elderly
por: Cannarella, Rossella, et al.
Publicado: (2019) -
Productivity Index in Clinical Andrology: Research Directions on High-Impact Topics and in Particular on Male Infertility
por: Crafa, Andrea, et al.
Publicado: (2023)